NEW YORK, Feb. 21 (GenomeWeb News) - Inpharmatica said today that it has licensed its Admensa Interactive suite of predictive drug absorption, distribution, metabolism, and excretion models and compound prioritization tools to biotech firm Serono.

Under the terms of the non-exclusive deal, Serono will receive a multi-site license to the Admensa technology, as well as training and ADME consulting. Additional terms were not disclosed.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.